Publications by authors named "Steven J Romano"

Claim this Profile
T
The Importance of Adequately Powered Clinical Studies: Response to Khan et al.
Stephen R Marder, Thomas Laughren, Steven J Romano

Am J Psychiatry· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Are Innovative Drugs Failing in Phase III?
Stephen R Marder, Thomas Laughren, Steven J Romano

Am J Psychiatry· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communication about results of comparative effectiveness studies: a pharmaceutical industry view.
Eleanor M Perfetto, John E Bailey, Kathleen R Gans-Brangs, Steven J Romano, Norman R Rosenthal

Health Aff (Millwood)· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new proposal for randomized start design to investigate disease-modifying therapies for Alzheimer disease.
Richard Y Zhang, Andrew C Leon, Christy Chuang-Stein, Steven J Romano

Clin Trials· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
Terence A Ketter, Ofer Agid, Shitij Kapur, Antony Loebel, Cynthia O Siu, Steven J Romano

J Psychiatr Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trial designs likely to meet valid long-term Alzheimer's disease progression effects: learning from the past, preparing for the future.
Aaron S Kemp, George T Grossberg, Steven J Romano, Douglas L Arnold, J Michael Ryan

Int J Alzheimers Dis· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: effect modification or regression to the mean?
David B Allison, Antony D Loebel, Ilise Lombardo, Steven J Romano, Cynthia O Siu

Psychiatry Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.
David L Dunner, Jay D Amsterdam, Richard C Shelton, Antony Loebel, Steven J Romano

J Clin Psychiatry· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
George M Simpson, Peter Weiden, Theresa Pigott, Stephen Murray, Cynthia O Siu, Steven J Romano

Am J Psychiatry· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study.
Shlomo Brook, Jeorg Walden, Isma Benattia, Cynthia O Siu, Steven J Romano

Psychopharmacology (Berl)· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Donald E N Addington, Christos Pantelis, Mary Dineen, Isma Benattia, Steven J Romano

J Clin Psychiatry· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
George M Simpson, Ira D Glick, Peter J Weiden, Steven J Romano, Cynthia O Siu

Am J Psychiatry· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.
Philip D Harvey, Herbert Meltzer, George M Simpson, Steven G Potkin, Antony Loebel, Steven J Romano

Schizophr Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
Peter J Weiden, David G Daniel, George Simpson, Steven J Romano

J Clin Psychopharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
Steven J Romano, Katherine A Halmi, Neena P Sarkar, Stephanie C Koke, Julia S Lee

Am J Psychiatry· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis